Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

17.77
+0.52003.01%
Post-market: 17.76-0.0100-0.06%18:06 EDT
Volume:11.57M
Turnover:203.95M
Market Cap:20.38B
PE:-15.55
High:17.83
Open:17.58
Low:17.34
Close:17.25
Loading ...

Teva Pharmaceuticals Initiated at Buy by Goldman Sachs

Dow Jones
·
Yesterday

Teva initiated with a Buy at Goldman Sachs

TIPRANKS
·
Yesterday

Teva Pharmaceutical Industries Raises Pool Tender Offer, Reports Early Tender Results

MT Newswires Live
·
03 Jun

Teva announces results from a study of treatment patterns of tardive dyskinesia

TIPRANKS
·
02 Jun

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

TIPRANKS
·
31 May

New Data From Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

THOMSON REUTERS
·
31 May

Teva Pharmaceutical (TEVA) Receives a Buy from UBS

TIPRANKS
·
30 May

Teva reaffirms ‘Pivot to Growth’ strategy with launch of acceleration phase

TIPRANKS
·
29 May

Teva Reaffirms “Pivot to Growth” Strategy Progress With Launch of Acceleration Phase at 2025 Innovation and Strategy Day

THOMSON REUTERS
·
29 May

Teva Pharmaceutical Issues Senior Notes for Debt Management

TIPRANKS
·
29 May

Teva : Truist Securities Initiates Coverage With Buy Rating; Target Price $25

THOMSON REUTERS
·
28 May

Truist Securities Initiates Teva Pharmaceutical Industries at Buy With $25 Price Target

MT Newswires Live
·
28 May

Teva receives FDA Fast Track designation for TEV-53408, an anti-IL-15 antibody

TIPRANKS
·
28 May

Teva initiated with a Buy at Truist

TIPRANKS
·
28 May

Teva Pharmaceutical Industries Begins Preclinical Testing of Inflammation Drug BD9

MT Newswires Live
·
27 May

Teva and Biolojic Design Initiate Ind-Enabling Studies of Bd9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

THOMSON REUTERS
·
27 May

Teva Pharmaceutical Industries Ltd - Biolojic to Receive Milestone Payments for Bd9 Development

THOMSON REUTERS
·
27 May

Press Release: Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

Dow Jones
·
23 May

Teva Pharmaceutical Prices Upsized $2.3 Billion Notes Offering

MT Newswires Live
·
21 May

Teva Pharmaceutical Plans Issuance of $2 Billion Equivalent of Senior Notes

MT Newswires Live
·
19 May